e-learning
resources
Paris 2018
Monday, 17.09.2018
Consequences of idiopathic interstitial pneumonias
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hospitalisation pattern in Interstitial Lung Diseases: a claims data study
S. Witt (München, Germany), J. Waelscher (Heidelberg, Germany), L. Schwarzkopf (München, Germany), M. Kreuter (Heidelberg, Germany)
Source:
International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Session:
Consequences of idiopathic interstitial pneumonias
Session type:
Thematic Poster
Number:
2909
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Witt (München, Germany), J. Waelscher (Heidelberg, Germany), L. Schwarzkopf (München, Germany), M. Kreuter (Heidelberg, Germany). Hospitalisation pattern in Interstitial Lung Diseases: a claims data study. 2909
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Romanian Registry for Interstitial Lung Diseases (REGIS): inclusion of patients in 3 years
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
Source: International Congress 2017 – Rare diseases
Year: 2017
The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Multicenter Registry of Interstitial Lung Diseases in Brazil
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
DANILDA – The First Danish National Interstitial Lung Disease Registry
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases.
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
The Severe Asthma Registry – German data
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Consequences of Lung Cancer: Mortality and Comorbidity in Danish Patients with Lung Cancer 1998-2010
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Causes of Hospitalization and Mortality in Lung Cancer Patients
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease
Source: Breathe 2014; 10:173-175
Year: 2014
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly
Source: ERJ Open Res, 6 (4) 00143-2020; 10.1183/23120541.00143-2020
Year: 2020
Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference?
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Rare diseases registries such as the Rare Lung Disease Registry Data Warehouse
Source: International Congress 2018 – Rare lung diseases
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept